Ad is loading...
SCHLX
Price
$42.19
Change
-$0.91 (-2.11%)
Updated
Nov 15 closing price
VGHCX
Price
$204.50
Change
-$5.96 (-2.83%)
Updated
Nov 15 closing price
Ad is loading...

SCHLX vs VGHCX

Header iconSCHLX vs VGHCX Comparison
Open Charts SCHLX vs VGHCXBanner chart's image
DWS Health and Wellness S
Price$42.19
Change-$0.91 (-2.11%)
VolumeN/A
CapitalizationN/A
Vanguard Health Care I
Price$204.50
Change-$5.96 (-2.83%)
VolumeN/A
CapitalizationN/A
SCHLX vs VGHCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SCHLX vs. VGHCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCHLX is a Sell and VGHCX is a Sell.

FUNDAMENTALS
Fundamentals
VGHCX has more cash in the bank: 45.7B vs. SCHLX (277M). VGHCX pays higher dividends than SCHLX: VGHCX (0.79) vs SCHLX (0.00). SCHLX was incepted earlier than VGHCX: SCHLX (27 years) vs VGHCX (41 years). SCHLX is a more actively managed with annual turnover of: 27.00 vs. VGHCX (16.00). SCHLX has a lower initial minimum investment than VGHCX: SCHLX (2500) vs VGHCX (3000). SCHLX annual gain was more profitable for investors over the last year : 8.18 vs. VGHCX (1.65). SCHLX return over 5 years is better than : 5.05 vs. VGHCX (-2.73).
SCHLXVGHCXSCHLX / VGHCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years41 years-
Gain YTD6.487-2.205-294%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets277M45.7B1%
Annual Yield % from dividends0.000.79-
Returns for 1 year8.181.65497%
Returns for 3 years-7.80-13.8556%
Returns for 5 years5.05-2.73-185%
Returns for 10 years-4.03-9.9441%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.31-0.24
-0.54%
UDR
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
OI12.97-0.17
-1.29%
O-I Glass
VIRX0.15-0.01
-4.37%
Viracta Therapeutics
PEPG4.12-0.37
-8.24%
PepGen